FDA Commissioner Scott Gottlieb Resigns

March 13, 2019

Scott Gottlieb, Commissioner of the Food and Drug Administration, surprised the country – and the cannabis industry – by announcing his plans to resign in the very near future.

Gottlieb was sworn into leadership of the FDA in May of 2017 and was regarded as a quiet yet effective leader. He was also seen as one of the “superstars” of the Trump Administration. Within the cannabis industry, he was viewed favorably and he seemed to have a thorough understanding of the challenges facing the CBD supplement industry.

gottlieb

Scott Gottlieb – photo courtesy of wikipedia.org

He was willing to working with various trade associations to find common ground. On multiple occasions, Gottlieb discussed creating a “pathway” for CBD to be used as a dietary ingredient. With his impending departure next month, many in the industry are questioning whether this will stall progress, or even end it completely.

President of the American Herbal Products Association Michael McGuffin described Gottlieb as the “most engaged commissioner” he’s had the pleasure of collaborating with in the decades he spent working for the supplements industry. “No other commissioner has embraced the agency, and his public role, anywhere near as effectively as Scott Gottlieb,” McGuffin said.

In his resignation letter, Gottlieb wrote: “I’m fortunate for the opportunity that the President of the United States afforded me to lead this outstanding team, at this time, in this period of wonderful scientific advances. There’s perhaps nothing that could pull me away from this role other than the challenge of being apart from my family for these past two years and missing my wife and three young children.” He also made sure to thank them for their sacrifices over the last couple of years while he was on the job.

While Gottlieb was making progress towards this cause, a new commissioner might take a very different approach and not be willing to work with the CBD and cannabis industry at all. Needless to say, this is a huge concern for everyone involved – businesses, patients, and consumers alike.

For updates on this developing story and other breaking industry news, make sure to subscribe to our Weekly Newsletter, the top source for all cannabis-related news and information.

The post FDA Commissioner Scott Gottlieb Resigns appeared first on Cannadelics.





Also in Education

Another Study Says Legalizations Don’t Increase Cannabis Use

August 07, 2022

The line is old and never made sense in the first place, but politician after politician like to extol the fear that if they legalize cannabis, everyone will become a pothead. As it turns out, study after study say the opposite, that legalizations don’t increase cannabis use, particularly in younger populations. Take a look. Yet […]

The post Another Study Says Legalizations Don’t Increase Cannabis Use appeared first on Cannadelics.

Continue Reading

Switzerland Implements Wide-Reaching Medical Cannabis Program

August 07, 2022

All eyes are on Switzerland as the country makes big moves to start its own cannabis industry. The country announced plans for a recreational measure last year, and now Switzerland is introducing a wide-reaching medical program that goes far beyond its previous limits. Switzerland is on a rampage, both widening its medical cannabis program, and […]

The post Switzerland Implements Wide-Reaching Medical Cannabis Program appeared first on Cannadelics.

Continue Reading

How Popular Are Psychedelics In America? Survey Says ~30% Have Tried

August 05, 2022

The psychedelics industry is gearing up for a massive debut, and opinions on the compounds are changing for the better. How popular are psychedelics in America right now? New survey results show that these compounds are not unknown to the American public, and that close to 30% of respondents, have already tried them. With the […]

The post How Popular Are Psychedelics In America? Survey Says ~30% Have Tried appeared first on Cannadelics.

Continue Reading

Summer Savings Sale